Discover 1,141 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,141
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
for
Chronic Lymphocytic Leukemia (CLL),
Location: New Haven CT, Philadelphia PA, Bethesda MD,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05131022
Phase1, Recruiting
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
for
Solid Tumor, Adult
Location: New Haven CT, Boston MA, Chicago IL, Birmingham AL,
Sponsor: Corbus Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT06265727
Phase1, Phase2, Recruiting
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
for
NSCLC (Advanced Non-small Cell Lung Cancer)
Location: New Haven CT, New York NY, Boston MA, Philadelphia PA,
Sponsor: BlossomHill Therapeutics
Sex: All
Age: 18+
Code: NCT06706076
Phase1, Phase2, Recruiting
A Study of BG-C477 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: New Haven CT, Hackensack NJ, Peoria IL, Jackson MS,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06596473
Phase1, Recruiting
Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors
for
Solid Tumor, Adult
Location: New Haven CT, Boston MA, Pittsburgh PA, Nashville TN,
Sponsor: Ribon Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04053673
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: New Haven CT, Shirley NY, The Bronx NY, Mineola NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06667076
Phase2, Recruiting
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab
for
Advanced Solid Cancer, Metastatic Solid Cancer
Location: New Haven CT, Hackensack NJ, Nashville TN
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07607678
Phase1, Recruiting
Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns
for
Metastatic Breast Cancer
Location: New Haven CT, Boston MA
Sponsor: Sun Yat-sen University
Sex: Female
Age: 18 - 70+
Code: NCT06551220
Recruiting
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
for
Breast Cancer, Metastatic Breast Cancer,
Location: New Haven CT, Philadelphia PA, Baltimore MD,
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07340541
Phase2, Recruiting
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
Location: New Haven CT, New York NY, Durham NC, Charleston SC,
Sponsor: CatalYm GmbH
Sex: All
Age: 18+
Code: NCT07098988
Phase2, Recruiting
A Study of GEN1106 in Participants With Solid Tumors
for
Solid Tumors, Urothelial Carcinoma
Location: New Haven CT, Lake Success NY, Myrtle Beach SC,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07416123
Phase1, Recruiting
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New Haven CT, Boston MA, Baltimore MD, Milwaukee WI,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07226349
Phase1, Recruiting
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: New Haven CT, New York NY, Hackensack NJ, Providence RI,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT07104032
Phase3, Recruiting
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: New Haven CT, Boston MA, Grand Rapids MI,
Sponsor: Ottimo Pharma Limited
Sex: All
Age: 18+
Code: NCT07266428
Phase1, Phase2, Recruiting
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
for
Small-cell Lung Cancer
Location: New Haven CT, Stony Brook NY, The Bronx NY, Broomall PA,
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07218146
Phase3, Recruiting
A Clinical Study of YL205 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: New Haven CT, Louisville KY, Denver CO, Nashville TX,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06459973
Phase1, Phase2, Recruiting
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: New Haven CT, New York NY, Boston MA, Baltimore MD,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07349537
Phase1, Recruiting
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
for
Breast Cancer, Advanced Solid Tumor
Location: New Haven CT, St Louis MO, Birmingham AL, Houston TX,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07222267
Phase1, Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: New Haven CT, Hartford CT, The Bronx NY, Mineola NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase3, Recruiting
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Cleveland OH, Durham NC,